| 000 | 00864 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20250518094559.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2531-1387 | ||
| 024 | 7 |
_a10.1016/j.htct.2020.02.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEllithi, Moataz | |
| 245 | 0 | 0 |
_aComplement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab. _h[electronic resource] |
| 260 |
_bHematology, transfusion and cell therapy _c |
||
| 300 |
_a364-367 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 700 | 1 | _aShahid, Mahum | |
| 700 | 1 | _aAbdullah, Hafez Mohammad | |
| 700 | 1 | _aBleeker, Jonathan | |
| 773 | 0 |
_tHematology, transfusion and cell therapy _gvol. 43 _gno. 3 _gp. 364-367 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.htct.2020.02.001 _zAvailable from publisher's website |
| 999 |
_c30832560 _d30832560 |
||